Dr. Leonor Matos is an Oncologist and clinical researcher at the Breast Unit, at the Champalimaud Clinical Center, Champalimaud Foundation, in Lisbon, Portugal. She has a Master in Medicine (New University of Lisbon), Master in Palliative Care (Portuguese Catholic University), and completed an internship at Instituto Tumori, in Milan, Italy. Dr. Matos has graduate training in Outcomes Research completed at the National School of Public Health in Lisbon, Portugal and was selected for the Harvard Medical School 2-year Clinical Scholars Research Training Program that she completed in 2020.
Dr. Matos has presented multiple research works at national and international meetings. She has published 19 scientific articles in journals indexed to Pubmed and is also a co-author of the International Consensus Guidelines for the Management of Advanced Breast Cancer. Dr. Matos has received 7 awards at scientific meetings for first-authorship research and a research grant for a prospective cohort study on integration of patient reported outcomes in oncology clinical practice.
Dr. Matos is the Principal investigator of the clinical trial NEO-PROGRAM, that evaluates the efficacy of a 4 to 6-month supervised exercise program, comparing aerobic vs. resistance exercise modalities, on tumor proliferation, quality of life, sleep quality and cardiorespiratory fitness, among patients with a diagnosis of breast cancer eligible to undergo neoadjuvant chemotherapy. She is also co-investigator in several clinical trials in breast cancer led by pharma. Dr. Matos is a member of various societies including the Interns and Young Specialists Group for the Portuguese Society for Oncology, the Portuguese Society of Oncology (SPO), the European Society of Medical Oncology (ESMO), the American Society of Medical Oncology (ASCO), and SOLTI – a clinical cancer research network based in Spain. Dr Matos has reviewed scientific papers for The Breast and the Journal of Geriatric Oncology.
